Please login to bookmark Close
A collapsed developer and its builder have failed again in their dispute against a financier over the Pentridge Village development in Melbourne, with an appeals court taking a critical view of years of delays.
Sayers wins fight with AIG over $11M land purchase dispute
Please login to bookmark Close
An appeals court has allowed developer Sayers Property’s $1.9 million insurance claim in relation to a $11 million purchase of land.
Snowy Hydro secures 2,200 MW in renewable capacity with new contracts
Please login to bookmark Close
The operator of the Snowy Mountains hydro-electric scheme has secured new partnerships with a South Australian wind farm and a Victorian battery storage facility.
Ampyr inks $300M deal with InCommodities for Bulabul BESS
Please login to bookmark Close
Renewable energy company Ampyr has signed a $300 million battery storage deal with Denmark-based energy trading company InCommodities.
Realterm adds $89M to pipeline with two Sydney industrial assets
Please login to bookmark Close
Global transport investment manager Realterm has acquired two logistics sites in Revesby and Ingleburn worth $89 million, expanding its Sydney portfolio to five assets.
AFL umpire loses unfair dismissal suit over alleged ‘frog marching’ incident
Please login to bookmark Close
An umpire has lost his unfair dismissal claim against the Australian Football League after he was accused of wrestling, man-handling and frog-marching a member of the public off the field.
ASIC seeks contempt orders against duo behind ALAMMC Developments
Please login to bookmark Close
ASIC wants a contempt ruling against the couple behind Gold Coast-based property developer ALAMMC Developments after they allegedly moved more than $500,000 out of frozen accounts and failed to disclose assets, including two racehorses, one of which is named ‘Within the Law’.
Regeneron, Bayer settle appeal over launch of Sandoz’s Eylea biosimilar
Please login to bookmark Close
Biotech Regeneron and drug company Bayer have resolved their appeal of a ruling that allowed generic pharmaceutical manufacturer Sandoz to launch a version of top selling macular degeneration drug Eylea.
Sportsbet brings class action cross-claim to claw back winnings
Please login to bookmark Close
Sportsbet has launched a cross-claim in a class action alleging it provided unlawful in-play betting services, arguing that users of the contentious service should have to pay back their winnings if the lawsuit succeeds.
Fortescue, Element Zero reach settlement in trade secrets case
Please login to bookmark Close
After losing a fight over access to millions of seized documents, Fortescue has settled its trade secrets case against green iron company Element Zero.